3 completed, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow N-Ac-CHAVC-NH2: new trials by email Literature Review of N-Ac-CHAVC-NH2 trials Research Report on N-Ac-CHAVC-NH2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer ADH-1, Cisplatin, Gemcitabine Hydrochloride - Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma | Phase 1 | Completed | University of Nebraska | 17 | 2013-04-09 | 2023-12-28 |
| Study of ADH-1 Given Intravenously to Patients With Solid Tumors ADH -1 (Exherin™) - Neoplasms | Phase 1 / Phase 2 | Completed | Adherex Technologies, Inc. | 2005-06-01 | 2010-12-28 | |
| A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors ADH -1 (Exherin™) - Neoplasms | Phase 1 / Phase 2 | Terminated | Adherex Technologies, Inc. | 2007-08-06 | ||
| A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent ADH -1 (Exherin™) - Neoplasms | Phase 2 | Completed | Adherex Technologies, Inc. | 2007-08-06 |
Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Adrenocortical Carcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Cholangiocarcinoma (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Klatskin Tumor (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Adherex Technologies, Inc. (3) · University of Nebraska (1)
United States (3) · Canada (1) · Italy (1) · Switzerland (1)
Jean L Grem, MD (1)
P30CA036727 (1), P50CA127297 (1)